nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—lung cancer	0.51	1	CbGaD
Pentobarbital—CYP2C19—Gefitinib—lung cancer	0.0306	0.176	CbGbCtD
Pentobarbital—CYP2C19—Teniposide—lung cancer	0.0296	0.17	CbGbCtD
Pentobarbital—CYP3A4—Topotecan—lung cancer	0.0162	0.0929	CbGbCtD
Pentobarbital—CYP3A4—Gefitinib—lung cancer	0.0148	0.0849	CbGbCtD
Pentobarbital—CYP3A4—Teniposide—lung cancer	0.0143	0.0824	CbGbCtD
Pentobarbital—CYP3A4—Vinorelbine—lung cancer	0.0114	0.0654	CbGbCtD
Pentobarbital—CYP3A4—Crizotinib—lung cancer	0.00906	0.0521	CbGbCtD
Pentobarbital—CYP3A4—Erlotinib—lung cancer	0.00874	0.0502	CbGbCtD
Pentobarbital—CYP3A4—Paclitaxel—lung cancer	0.008	0.046	CbGbCtD
Pentobarbital—CYP3A4—Irinotecan—lung cancer	0.00789	0.0454	CbGbCtD
Pentobarbital—CYP3A4—Vinblastine—lung cancer	0.00702	0.0403	CbGbCtD
Pentobarbital—CYP3A4—Etoposide—lung cancer	0.00632	0.0363	CbGbCtD
Pentobarbital—CYP3A4—Docetaxel—lung cancer	0.00578	0.0332	CbGbCtD
Pentobarbital—CYP3A4—Doxorubicin—lung cancer	0.00431	0.0248	CbGbCtD
Pentobarbital—Hypoxia—Gefitinib—lung cancer	0.00429	0.0333	CcSEcCtD
Pentobarbital—Respiratory failure—Crizotinib—lung cancer	0.00306	0.0237	CcSEcCtD
Pentobarbital—Respiratory failure—Pemetrexed—lung cancer	0.0028	0.0217	CcSEcCtD
Pentobarbital—Respiratory failure—Gefitinib—lung cancer	0.00278	0.0215	CcSEcCtD
Pentobarbital—Anaemia megaloblastic—Methotrexate—lung cancer	0.00246	0.0191	CcSEcCtD
Pentobarbital—Hypoxia—Vinorelbine—lung cancer	0.00222	0.0172	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Gefitinib—lung cancer	0.0021	0.0163	CcSEcCtD
Pentobarbital—Hypoxia—Gemcitabine—lung cancer	0.00178	0.0138	CcSEcCtD
Pentobarbital—Respiratory failure—Topotecan—lung cancer	0.00168	0.013	CcSEcCtD
Pentobarbital—Hepatocellular injury—Erlotinib—lung cancer	0.00163	0.0126	CcSEcCtD
Pentobarbital—Bradycardia—Crizotinib—lung cancer	0.00154	0.0119	CcSEcCtD
Pentobarbital—Respiratory failure—Vinorelbine—lung cancer	0.00144	0.0111	CcSEcCtD
Pentobarbital—Injection site reaction—Vinorelbine—lung cancer	0.0014	0.0109	CcSEcCtD
Pentobarbital—Liver injury—Cisplatin—lung cancer	0.00125	0.00972	CcSEcCtD
Pentobarbital—Syncope—Crizotinib—lung cancer	0.00118	0.00913	CcSEcCtD
Pentobarbital—Loss of consciousness—Crizotinib—lung cancer	0.00115	0.00895	CcSEcCtD
Pentobarbital—Respiratory failure—Gemcitabine—lung cancer	0.00115	0.00894	CcSEcCtD
Pentobarbital—Apnoea—Etoposide—lung cancer	0.00114	0.00884	CcSEcCtD
Pentobarbital—Injection site reaction—Gemcitabine—lung cancer	0.00113	0.00873	CcSEcCtD
Pentobarbital—Angioedema—Gefitinib—lung cancer	0.00109	0.00844	CcSEcCtD
Pentobarbital—Syncope—Pemetrexed—lung cancer	0.00108	0.00834	CcSEcCtD
Pentobarbital—Hepatocellular injury—Cisplatin—lung cancer	0.00106	0.00818	CcSEcCtD
Pentobarbital—Loss of consciousness—Pemetrexed—lung cancer	0.00105	0.00818	CcSEcCtD
Pentobarbital—Shock—Crizotinib—lung cancer	0.00105	0.00817	CcSEcCtD
Pentobarbital—Respiratory failure—Paclitaxel—lung cancer	0.000966	0.00748	CcSEcCtD
Pentobarbital—Shock—Pemetrexed—lung cancer	0.000964	0.00747	CcSEcCtD
Pentobarbital—Shock—Gefitinib—lung cancer	0.000958	0.00742	CcSEcCtD
Pentobarbital—Injection site reaction—Paclitaxel—lung cancer	0.000943	0.00731	CcSEcCtD
Pentobarbital—Constipation—Crizotinib—lung cancer	0.000917	0.0071	CcSEcCtD
Pentobarbital—Hypoxia—Methotrexate—lung cancer	0.000912	0.00707	CcSEcCtD
Pentobarbital—Hypotension—Gefitinib—lung cancer	0.000909	0.00705	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Irinotecan—lung cancer	0.000895	0.00693	CcSEcCtD
Pentobarbital—Agitation—Teniposide—lung cancer	0.000893	0.00692	CcSEcCtD
Pentobarbital—Body temperature increased—Crizotinib—lung cancer	0.000847	0.00657	CcSEcCtD
Pentobarbital—Constipation—Pemetrexed—lung cancer	0.000838	0.00649	CcSEcCtD
Pentobarbital—Constipation—Gefitinib—lung cancer	0.000832	0.00645	CcSEcCtD
Pentobarbital—Respiratory failure—Docetaxel—lung cancer	0.000819	0.00634	CcSEcCtD
Pentobarbital—Hepatocellular injury—Docetaxel—lung cancer	0.000804	0.00623	CcSEcCtD
Pentobarbital—Confusional state—Teniposide—lung cancer	0.0008	0.0062	CcSEcCtD
Pentobarbital—Injection site reaction—Docetaxel—lung cancer	0.000799	0.00619	CcSEcCtD
Pentobarbital—Body temperature increased—Pemetrexed—lung cancer	0.000774	0.006	CcSEcCtD
Pentobarbital—Body temperature increased—Gefitinib—lung cancer	0.000769	0.00596	CcSEcCtD
Pentobarbital—Phenobarbital—ABCC3—lung cancer	0.000768	0.25	CrCbGaD
Pentobarbital—Hypotension—Teniposide—lung cancer	0.000741	0.00575	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Paclitaxel—lung cancer	0.00073	0.00565	CcSEcCtD
Pentobarbital—Hypersensitivity—Pemetrexed—lung cancer	0.000722	0.00559	CcSEcCtD
Pentobarbital—Hypersensitivity—Gefitinib—lung cancer	0.000717	0.00556	CcSEcCtD
Pentobarbital—Dizziness—Crizotinib—lung cancer	0.000709	0.00549	CcSEcCtD
Pentobarbital—Apnoea—Methotrexate—lung cancer	0.000684	0.0053	CcSEcCtD
Pentobarbital—Vomiting—Crizotinib—lung cancer	0.000682	0.00528	CcSEcCtD
Pentobarbital—Rash—Crizotinib—lung cancer	0.000676	0.00524	CcSEcCtD
Pentobarbital—Dermatitis—Crizotinib—lung cancer	0.000675	0.00523	CcSEcCtD
Pentobarbital—Amobarbital—CYP2A6—lung cancer	0.000662	0.216	CrCbGaD
Pentobarbital—Angioedema—Topotecan—lung cancer	0.000658	0.0051	CcSEcCtD
Pentobarbital—Feeling abnormal—Teniposide—lung cancer	0.000654	0.00507	CcSEcCtD
Pentobarbital—Dizziness—Pemetrexed—lung cancer	0.000648	0.00502	CcSEcCtD
Pentobarbital—Ataxia—Paclitaxel—lung cancer	0.000647	0.00502	CcSEcCtD
Pentobarbital—Syncope—Erlotinib—lung cancer	0.000639	0.00495	CcSEcCtD
Pentobarbital—Nausea—Crizotinib—lung cancer	0.000637	0.00493	CcSEcCtD
Pentobarbital—Body temperature increased—Teniposide—lung cancer	0.000627	0.00486	CcSEcCtD
Pentobarbital—Loss of consciousness—Erlotinib—lung cancer	0.000627	0.00486	CcSEcCtD
Pentobarbital—Vomiting—Pemetrexed—lung cancer	0.000623	0.00483	CcSEcCtD
Pentobarbital—Vomiting—Gefitinib—lung cancer	0.000619	0.0048	CcSEcCtD
Pentobarbital—Rash—Pemetrexed—lung cancer	0.000618	0.00479	CcSEcCtD
Pentobarbital—Dermatitis—Pemetrexed—lung cancer	0.000617	0.00478	CcSEcCtD
Pentobarbital—Rash—Gefitinib—lung cancer	0.000614	0.00476	CcSEcCtD
Pentobarbital—Dermatitis—Gefitinib—lung cancer	0.000613	0.00475	CcSEcCtD
Pentobarbital—Anxiety—Erlotinib—lung cancer	0.000605	0.00469	CcSEcCtD
Pentobarbital—Liver injury—Doxorubicin—lung cancer	0.000596	0.00462	CcSEcCtD
Pentobarbital—Bradycardia—Irinotecan—lung cancer	0.000595	0.00461	CcSEcCtD
Pentobarbital—Respiratory failure—Methotrexate—lung cancer	0.00059	0.00457	CcSEcCtD
Pentobarbital—Hypersensitivity—Teniposide—lung cancer	0.000585	0.00453	CcSEcCtD
Pentobarbital—Nausea—Pemetrexed—lung cancer	0.000582	0.00451	CcSEcCtD
Pentobarbital—Nausea—Gefitinib—lung cancer	0.000578	0.00448	CcSEcCtD
Pentobarbital—Shock—Erlotinib—lung cancer	0.000572	0.00444	CcSEcCtD
Pentobarbital—Angioedema—Vinorelbine—lung cancer	0.000563	0.00437	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Methotrexate—lung cancer	0.000559	0.00434	CcSEcCtD
Pentobarbital—Ataxia—Docetaxel—lung cancer	0.000549	0.00425	CcSEcCtD
Pentobarbital—Bradycardia—Cisplatin—lung cancer	0.00054	0.00418	CcSEcCtD
Pentobarbital—Constipation—Vinblastine—lung cancer	0.000518	0.00401	CcSEcCtD
Pentobarbital—Vomiting—Teniposide—lung cancer	0.000504	0.00391	CcSEcCtD
Pentobarbital—Constipation—Topotecan—lung cancer	0.000503	0.0039	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—lung cancer	0.000502	0.00389	CcSEcCtD
Pentobarbital—Rash—Teniposide—lung cancer	0.0005	0.00388	CcSEcCtD
Pentobarbital—Dermatitis—Teniposide—lung cancer	0.0005	0.00387	CcSEcCtD
Pentobarbital—Feeling abnormal—Vinblastine—lung cancer	0.000499	0.00387	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—lung cancer	0.000499	0.00387	CcSEcCtD
Pentobarbital—Constipation—Erlotinib—lung cancer	0.000498	0.00386	CcSEcCtD
Pentobarbital—Headache—Teniposide—lung cancer	0.000497	0.00385	CcSEcCtD
Pentobarbital—Bradycardia—Paclitaxel—lung cancer	0.000485	0.00376	CcSEcCtD
Pentobarbital—Feeling abnormal—Topotecan—lung cancer	0.000485	0.00376	CcSEcCtD
Pentobarbital—Thiopental—CYP2E1—lung cancer	0.000476	0.155	CrCbGaD
Pentobarbital—Nausea—Teniposide—lung cancer	0.000471	0.00365	CcSEcCtD
Pentobarbital—Hypotension—Vinorelbine—lung cancer	0.00047	0.00364	CcSEcCtD
Pentobarbital—Body temperature increased—Topotecan—lung cancer	0.000465	0.0036	CcSEcCtD
Pentobarbital—Body temperature increased—Erlotinib—lung cancer	0.00046	0.00356	CcSEcCtD
Pentobarbital—Syncope—Irinotecan—lung cancer	0.000456	0.00353	CcSEcCtD
Pentobarbital—Loss of consciousness—Irinotecan—lung cancer	0.000447	0.00346	CcSEcCtD
Pentobarbital—Hypersensitivity—Vinblastine—lung cancer	0.000446	0.00346	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Methotrexate—lung cancer	0.000446	0.00345	CcSEcCtD
Pentobarbital—Hypersensitivity—Topotecan—lung cancer	0.000433	0.00336	CcSEcCtD
Pentobarbital—Constipation—Vinorelbine—lung cancer	0.00043	0.00333	CcSEcCtD
Pentobarbital—Confusional state—Irinotecan—lung cancer	0.000418	0.00324	CcSEcCtD
Pentobarbital—Phenobarbital—CYP2A6—lung cancer	0.000417	0.136	CrCbGaD
Pentobarbital—Feeling abnormal—Vinorelbine—lung cancer	0.000415	0.00321	CcSEcCtD
Pentobarbital—Shock—Irinotecan—lung cancer	0.000408	0.00316	CcSEcCtD
Pentobarbital—Tension—Paclitaxel—lung cancer	0.000407	0.00315	CcSEcCtD
Pentobarbital—Nervousness—Paclitaxel—lung cancer	0.000403	0.00312	CcSEcCtD
Pentobarbital—Dizziness—Vinblastine—lung cancer	0.0004	0.0031	CcSEcCtD
Pentobarbital—Body temperature increased—Vinorelbine—lung cancer	0.000398	0.00308	CcSEcCtD
Pentobarbital—Ataxia—Methotrexate—lung cancer	0.000395	0.00306	CcSEcCtD
Pentobarbital—Anxiety—Cisplatin—lung cancer	0.000392	0.00303	CcSEcCtD
Pentobarbital—Dizziness—Topotecan—lung cancer	0.000389	0.00301	CcSEcCtD
Pentobarbital—Hypotension—Irinotecan—lung cancer	0.000388	0.003	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000386	0.00299	CcSEcCtD
Pentobarbital—Vomiting—Vinblastine—lung cancer	0.000385	0.00298	CcSEcCtD
Pentobarbital—Dizziness—Erlotinib—lung cancer	0.000385	0.00298	CcSEcCtD
Pentobarbital—Agitation—Paclitaxel—lung cancer	0.000381	0.00295	CcSEcCtD
Pentobarbital—Headache—Vinblastine—lung cancer	0.000379	0.00294	CcSEcCtD
Pentobarbital—Angioedema—Paclitaxel—lung cancer	0.000379	0.00294	CcSEcCtD
Pentobarbital—Hypotension—Gemcitabine—lung cancer	0.000378	0.00293	CcSEcCtD
Pentobarbital—Vomiting—Topotecan—lung cancer	0.000374	0.0029	CcSEcCtD
Pentobarbital—Syncope—Paclitaxel—lung cancer	0.000372	0.00288	CcSEcCtD
Pentobarbital—Loss of consciousness—Etoposide—lung cancer	0.000372	0.00288	CcSEcCtD
Pentobarbital—Rash—Topotecan—lung cancer	0.000371	0.00287	CcSEcCtD
Pentobarbital—Hypersensitivity—Vinorelbine—lung cancer	0.000371	0.00287	CcSEcCtD
Pentobarbital—Dermatitis—Topotecan—lung cancer	0.00037	0.00287	CcSEcCtD
Pentobarbital—Vomiting—Erlotinib—lung cancer	0.00037	0.00287	CcSEcCtD
Pentobarbital—Somnolence—Irinotecan—lung cancer	0.000369	0.00286	CcSEcCtD
Pentobarbital—Headache—Topotecan—lung cancer	0.000368	0.00286	CcSEcCtD
Pentobarbital—Rash—Erlotinib—lung cancer	0.000367	0.00284	CcSEcCtD
Pentobarbital—Dermatitis—Erlotinib—lung cancer	0.000367	0.00284	CcSEcCtD
Pentobarbital—Headache—Erlotinib—lung cancer	0.000365	0.00282	CcSEcCtD
Pentobarbital—Loss of consciousness—Paclitaxel—lung cancer	0.000364	0.00282	CcSEcCtD
Pentobarbital—Nausea—Vinblastine—lung cancer	0.00036	0.00279	CcSEcCtD
Pentobarbital—Somnolence—Gemcitabine—lung cancer	0.000359	0.00278	CcSEcCtD
Pentobarbital—Constipation—Irinotecan—lung cancer	0.000355	0.00275	CcSEcCtD
Pentobarbital—Hypotension—Cisplatin—lung cancer	0.000352	0.00273	CcSEcCtD
Pentobarbital—Anxiety—Paclitaxel—lung cancer	0.000352	0.00273	CcSEcCtD
Pentobarbital—Nausea—Topotecan—lung cancer	0.000349	0.00271	CcSEcCtD
Pentobarbital—Confusional state—Etoposide—lung cancer	0.000348	0.0027	CcSEcCtD
Pentobarbital—Constipation—Gemcitabine—lung cancer	0.000346	0.00268	CcSEcCtD
Pentobarbital—Nausea—Erlotinib—lung cancer	0.000346	0.00268	CcSEcCtD
Pentobarbital—Ataxia—Doxorubicin—lung cancer	0.000342	0.00265	CcSEcCtD
Pentobarbital—Feeling abnormal—Irinotecan—lung cancer	0.000342	0.00265	CcSEcCtD
Pentobarbital—Confusional state—Paclitaxel—lung cancer	0.000341	0.00264	CcSEcCtD
Pentobarbital—Feeling abnormal—Gemcitabine—lung cancer	0.000333	0.00258	CcSEcCtD
Pentobarbital—Shock—Paclitaxel—lung cancer	0.000333	0.00258	CcSEcCtD
Pentobarbital—Dizziness—Vinorelbine—lung cancer	0.000333	0.00258	CcSEcCtD
Pentobarbital—Body temperature increased—Irinotecan—lung cancer	0.000328	0.00254	CcSEcCtD
Pentobarbital—Hypotension—Etoposide—lung cancer	0.000322	0.0025	CcSEcCtD
Pentobarbital—Vomiting—Vinorelbine—lung cancer	0.00032	0.00248	CcSEcCtD
Pentobarbital—Body temperature increased—Gemcitabine—lung cancer	0.000319	0.00248	CcSEcCtD
Pentobarbital—Rash—Vinorelbine—lung cancer	0.000317	0.00246	CcSEcCtD
Pentobarbital—Dermatitis—Vinorelbine—lung cancer	0.000317	0.00246	CcSEcCtD
Pentobarbital—Hypotension—Paclitaxel—lung cancer	0.000316	0.00245	CcSEcCtD
Pentobarbital—Headache—Vinorelbine—lung cancer	0.000315	0.00244	CcSEcCtD
Pentobarbital—Syncope—Docetaxel—lung cancer	0.000315	0.00244	CcSEcCtD
Pentobarbital—Feeling abnormal—Cisplatin—lung cancer	0.00031	0.00241	CcSEcCtD
Pentobarbital—Loss of consciousness—Docetaxel—lung cancer	0.000309	0.00239	CcSEcCtD
Pentobarbital—Somnolence—Etoposide—lung cancer	0.000307	0.00238	CcSEcCtD
Pentobarbital—Hypersensitivity—Irinotecan—lung cancer	0.000306	0.00237	CcSEcCtD
Pentobarbital—Somnolence—Paclitaxel—lung cancer	0.000301	0.00233	CcSEcCtD
Pentobarbital—Nausea—Vinorelbine—lung cancer	0.000299	0.00232	CcSEcCtD
Pentobarbital—Body temperature increased—Cisplatin—lung cancer	0.000298	0.00231	CcSEcCtD
Pentobarbital—Phenobarbital—CYP2E1—lung cancer	0.000296	0.0965	CrCbGaD
Pentobarbital—Constipation—Etoposide—lung cancer	0.000295	0.00229	CcSEcCtD
Pentobarbital—Phenobarbital—CYP1A1—lung cancer	0.000292	0.0952	CrCbGaD
Pentobarbital—Constipation—Paclitaxel—lung cancer	0.000289	0.00224	CcSEcCtD
Pentobarbital—Confusional state—Docetaxel—lung cancer	0.000289	0.00224	CcSEcCtD
Pentobarbital—Feeling abnormal—Etoposide—lung cancer	0.000284	0.0022	CcSEcCtD
Pentobarbital—Shock—Docetaxel—lung cancer	0.000282	0.00219	CcSEcCtD
Pentobarbital—Feeling abnormal—Paclitaxel—lung cancer	0.000279	0.00216	CcSEcCtD
Pentobarbital—Hypersensitivity—Cisplatin—lung cancer	0.000278	0.00215	CcSEcCtD
Pentobarbital—Dizziness—Irinotecan—lung cancer	0.000274	0.00213	CcSEcCtD
Pentobarbital—Body temperature increased—Etoposide—lung cancer	0.000273	0.00211	CcSEcCtD
Pentobarbital—Hypotension—Docetaxel—lung cancer	0.000268	0.00208	CcSEcCtD
Pentobarbital—Body temperature increased—Paclitaxel—lung cancer	0.000267	0.00207	CcSEcCtD
Pentobarbital—Vomiting—Irinotecan—lung cancer	0.000264	0.00204	CcSEcCtD
Pentobarbital—Rash—Irinotecan—lung cancer	0.000262	0.00203	CcSEcCtD
Pentobarbital—Dermatitis—Irinotecan—lung cancer	0.000261	0.00203	CcSEcCtD
Pentobarbital—Headache—Irinotecan—lung cancer	0.00026	0.00201	CcSEcCtD
Pentobarbital—Vomiting—Gemcitabine—lung cancer	0.000257	0.00199	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—lung cancer	0.000256	0.00199	CcSEcCtD
Pentobarbital—Somnolence—Docetaxel—lung cancer	0.000255	0.00198	CcSEcCtD
Pentobarbital—Rash—Gemcitabine—lung cancer	0.000255	0.00197	CcSEcCtD
Pentobarbital—Dermatitis—Gemcitabine—lung cancer	0.000255	0.00197	CcSEcCtD
Pentobarbital—Hypersensitivity—Etoposide—lung cancer	0.000254	0.00197	CcSEcCtD
Pentobarbital—Headache—Gemcitabine—lung cancer	0.000253	0.00196	CcSEcCtD
Pentobarbital—Hypersensitivity—Paclitaxel—lung cancer	0.000249	0.00193	CcSEcCtD
Pentobarbital—Nausea—Irinotecan—lung cancer	0.000246	0.00191	CcSEcCtD
Pentobarbital—Constipation—Docetaxel—lung cancer	0.000245	0.0019	CcSEcCtD
Pentobarbital—Nausea—Gemcitabine—lung cancer	0.00024	0.00186	CcSEcCtD
Pentobarbital—Vomiting—Cisplatin—lung cancer	0.00024	0.00186	CcSEcCtD
Pentobarbital—Rash—Cisplatin—lung cancer	0.000238	0.00184	CcSEcCtD
Pentobarbital—Dermatitis—Cisplatin—lung cancer	0.000237	0.00184	CcSEcCtD
Pentobarbital—Feeling abnormal—Docetaxel—lung cancer	0.000236	0.00183	CcSEcCtD
Pentobarbital—Dizziness—Etoposide—lung cancer	0.000228	0.00177	CcSEcCtD
Pentobarbital—Body temperature increased—Docetaxel—lung cancer	0.000227	0.00176	CcSEcCtD
Pentobarbital—Dizziness—Paclitaxel—lung cancer	0.000224	0.00173	CcSEcCtD
Pentobarbital—Nausea—Cisplatin—lung cancer	0.000224	0.00173	CcSEcCtD
Pentobarbital—Vomiting—Etoposide—lung cancer	0.000219	0.0017	CcSEcCtD
Pentobarbital—Rash—Etoposide—lung cancer	0.000218	0.00169	CcSEcCtD
Pentobarbital—Dermatitis—Etoposide—lung cancer	0.000217	0.00168	CcSEcCtD
Pentobarbital—Headache—Etoposide—lung cancer	0.000216	0.00168	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—lung cancer	0.000215	0.00167	CcSEcCtD
Pentobarbital—Vomiting—Paclitaxel—lung cancer	0.000215	0.00167	CcSEcCtD
Pentobarbital—Rash—Paclitaxel—lung cancer	0.000213	0.00165	CcSEcCtD
Pentobarbital—Dermatitis—Paclitaxel—lung cancer	0.000213	0.00165	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—lung cancer	0.000213	0.00165	CcSEcCtD
Pentobarbital—Headache—Paclitaxel—lung cancer	0.000212	0.00164	CcSEcCtD
Pentobarbital—Hypersensitivity—Docetaxel—lung cancer	0.000211	0.00164	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—lung cancer	0.000208	0.00162	CcSEcCtD
Pentobarbital—Nausea—Etoposide—lung cancer	0.000205	0.00159	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—lung cancer	0.000202	0.00156	CcSEcCtD
Pentobarbital—Nausea—Paclitaxel—lung cancer	0.000201	0.00156	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—lung cancer	0.000197	0.00152	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—lung cancer	0.000193	0.0015	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—lung cancer	0.000193	0.00149	CcSEcCtD
Pentobarbital—Dizziness—Docetaxel—lung cancer	0.00019	0.00147	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—lung cancer	0.000186	0.00144	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—lung cancer	0.000184	0.00142	CcSEcCtD
Pentobarbital—Vomiting—Docetaxel—lung cancer	0.000182	0.00141	CcSEcCtD
Pentobarbital—Rash—Docetaxel—lung cancer	0.000181	0.0014	CcSEcCtD
Pentobarbital—Dermatitis—Docetaxel—lung cancer	0.000181	0.0014	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—lung cancer	0.00018	0.0014	CcSEcCtD
Pentobarbital—Headache—Docetaxel—lung cancer	0.00018	0.00139	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—lung cancer	0.000176	0.00136	CcSEcCtD
Pentobarbital—Nausea—Docetaxel—lung cancer	0.00017	0.00132	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—lung cancer	0.00017	0.00132	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—lung cancer	0.000167	0.0013	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—lung cancer	0.000163	0.00127	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—lung cancer	0.000159	0.00123	CcSEcCtD
Pentobarbital—Phenobarbital—ABCB1—lung cancer	0.000155	0.0506	CrCbGaD
Pentobarbital—Constipation—Doxorubicin—lung cancer	0.000153	0.00119	CcSEcCtD
Pentobarbital—Hypersensitivity—Methotrexate—lung cancer	0.000152	0.00118	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—lung cancer	0.000148	0.00114	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—lung cancer	0.000142	0.0011	CcSEcCtD
Pentobarbital—Dizziness—Methotrexate—lung cancer	0.000137	0.00106	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—lung cancer	0.000132	0.00102	CcSEcCtD
Pentobarbital—Vomiting—Methotrexate—lung cancer	0.000131	0.00102	CcSEcCtD
Pentobarbital—Rash—Methotrexate—lung cancer	0.00013	0.00101	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—lung cancer	0.00013	0.00101	CcSEcCtD
Pentobarbital—Headache—Methotrexate—lung cancer	0.00013	0.001	CcSEcCtD
Pentobarbital—Nausea—Methotrexate—lung cancer	0.000123	0.000952	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—lung cancer	0.000118	0.000917	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—lung cancer	0.000114	0.000882	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—lung cancer	0.000113	0.000875	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—lung cancer	0.000113	0.000874	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—lung cancer	0.000112	0.000869	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—lung cancer	0.000106	0.000824	CcSEcCtD
Pentobarbital—GABRB3—BDNF signaling pathway—HRAS—lung cancer	3.12e-05	0.00017	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—lung cancer	3.11e-05	0.000169	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AZIN2—lung cancer	3.1e-05	0.000169	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—COL4A3BP—lung cancer	3.1e-05	0.000169	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM2—lung cancer	3.08e-05	0.000168	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CNDP2—lung cancer	3.08e-05	0.000168	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTMR3—lung cancer	3e-05	0.000163	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—APOA1—lung cancer	2.98e-05	0.000162	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.97e-05	0.000162	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP2E1—lung cancer	2.95e-05	0.000161	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—APOA1—lung cancer	2.94e-05	0.00016	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PGAM1—lung cancer	2.92e-05	0.000159	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.91e-05	0.000158	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	2.89e-05	0.000157	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—MDM2—lung cancer	2.87e-05	0.000156	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—RAF1—lung cancer	2.86e-05	0.000156	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—lung cancer	2.85e-05	0.000155	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—lung cancer	2.81e-05	0.000153	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—AVP—lung cancer	2.81e-05	0.000153	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	2.8e-05	0.000152	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2A7—lung cancer	2.79e-05	0.000152	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—AKT1—lung cancer	2.75e-05	0.00015	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	2.74e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SDC4—lung cancer	2.73e-05	0.000148	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—lung cancer	2.72e-05	0.000148	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—APOA1—lung cancer	2.69e-05	0.000146	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ATP5H—lung cancer	2.64e-05	0.000143	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—POMC—lung cancer	2.63e-05	0.000143	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—HRAS—lung cancer	2.63e-05	0.000143	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—APOA1—lung cancer	2.61e-05	0.000142	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—HRAS—lung cancer	2.57e-05	0.00014	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—APOA1—lung cancer	2.56e-05	0.00014	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—HRAS—lung cancer	2.55e-05	0.000139	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—APOA1—lung cancer	2.52e-05	0.000137	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—CREBBP—lung cancer	2.52e-05	0.000137	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—APOA1—lung cancer	2.5e-05	0.000136	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—lung cancer	2.5e-05	0.000136	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—CREBBP—lung cancer	2.49e-05	0.000135	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—RRM1—lung cancer	2.48e-05	0.000135	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTA3—lung cancer	2.48e-05	0.000135	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—APOA1—lung cancer	2.46e-05	0.000134	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—lung cancer	2.45e-05	0.000134	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.43e-05	0.000132	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.42e-05	0.000132	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—lung cancer	2.41e-05	0.000131	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	2.4e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.4e-05	0.000131	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—HRAS—lung cancer	2.4e-05	0.00013	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ALB—lung cancer	2.36e-05	0.000128	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	2.35e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PLBD1—lung cancer	2.35e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—B4GALT5—lung cancer	2.33e-05	0.000127	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ALB—lung cancer	2.33e-05	0.000127	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.31e-05	0.000126	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.27e-05	0.000124	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTA4—lung cancer	2.27e-05	0.000124	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.24e-05	0.000122	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTA2—lung cancer	2.21e-05	0.00012	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—CREBBP—lung cancer	2.21e-05	0.00012	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.2e-05	0.00012	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—HRAS—lung cancer	2.18e-05	0.000119	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—CREBBP—lung cancer	2.17e-05	0.000118	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—HRAS—lung cancer	2.16e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSD17B10—lung cancer	2.15e-05	0.000117	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	2.15e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTA1—lung cancer	2.13e-05	0.000116	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.13e-05	0.000116	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—lung cancer	2.13e-05	0.000116	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ALB—lung cancer	2.13e-05	0.000116	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.12e-05	0.000115	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—CREBBP—lung cancer	2.12e-05	0.000115	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCC3—lung cancer	2.11e-05	0.000115	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—lung cancer	2.1e-05	0.000115	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.09e-05	0.000114	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.08e-05	0.000113	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ALB—lung cancer	2.07e-05	0.000113	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	2.06e-05	0.000112	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKR1C1—lung cancer	2.04e-05	0.000111	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ALB—lung cancer	2.03e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CKB—lung cancer	2e-05	0.000109	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ALB—lung cancer	2e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—UGT1A1—lung cancer	1.98e-05	0.000108	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ALB—lung cancer	1.98e-05	0.000108	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—HRAS—lung cancer	1.97e-05	0.000107	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	1.95e-05	0.000106	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—RAF1—lung cancer	1.93e-05	0.000105	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—HRAS—lung cancer	1.92e-05	0.000104	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GNG11—lung cancer	1.91e-05	0.000104	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—HRAS—lung cancer	1.88e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CNDP2—lung cancer	1.88e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM2—lung cancer	1.88e-05	0.000102	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—lung cancer	1.87e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AZIN2—lung cancer	1.86e-05	0.000101	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.86e-05	0.000101	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—HRAS—lung cancer	1.85e-05	0.000101	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—lung cancer	1.84e-05	0.0001	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—HRAS—lung cancer	1.84e-05	0.0001	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTMR3—lung cancer	1.83e-05	9.95e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALDOA—lung cancer	1.82e-05	9.92e-05	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.82e-05	9.9e-05	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	1.8e-05	9.83e-05	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—HRAS—lung cancer	1.8e-05	9.82e-05	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	1.79e-05	9.76e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PGAM1—lung cancer	1.78e-05	9.69e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOA3—lung cancer	1.77e-05	9.63e-05	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	1.76e-05	9.59e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCG2—lung cancer	1.72e-05	9.37e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ADCY1—lung cancer	1.72e-05	9.37e-05	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	1.7e-05	9.27e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2A7—lung cancer	1.7e-05	9.25e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HPGDS—lung cancer	1.69e-05	9.19e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ENO2—lung cancer	1.69e-05	9.19e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPP2R1B—lung cancer	1.68e-05	9.13e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SDC4—lung cancer	1.66e-05	9.05e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—lung cancer	1.64e-05	8.91e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GCLC—lung cancer	1.62e-05	8.81e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ATP5H—lung cancer	1.58e-05	8.63e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—POMC—lung cancer	1.58e-05	8.6e-05	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—HRAS—lung cancer	1.58e-05	8.58e-05	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	1.54e-05	8.38e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ENO1—lung cancer	1.53e-05	8.35e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—RRM1—lung cancer	1.51e-05	8.24e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA3—lung cancer	1.51e-05	8.24e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—B4GALT5—lung cancer	1.42e-05	7.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PLBD1—lung cancer	1.41e-05	7.69e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA4—lung cancer	1.38e-05	7.54e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2E1—lung cancer	1.38e-05	7.49e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NQO1—lung cancer	1.36e-05	7.41e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.35e-05	7.37e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA2—lung cancer	1.35e-05	7.35e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTA1—lung cancer	1.3e-05	7.09e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD17B10—lung cancer	1.29e-05	7.03e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCC3—lung cancer	1.29e-05	7.01e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKR1C1—lung cancer	1.25e-05	6.79e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—STK11—lung cancer	1.23e-05	6.68e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UGT1A1—lung cancer	1.21e-05	6.59e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CKB—lung cancer	1.2e-05	6.54e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GNG11—lung cancer	1.17e-05	6.35e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.16e-05	6.32e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—lung cancer	1.13e-05	6.18e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM2—lung cancer	1.13e-05	6.15e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CNDP2—lung cancer	1.13e-05	6.15e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALDOA—lung cancer	1.11e-05	6.05e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CAT—lung cancer	1.1e-05	6.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTMR3—lung cancer	1.1e-05	5.98e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA3—lung cancer	1.08e-05	5.87e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCB1—lung cancer	1.07e-05	5.85e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PGAM1—lung cancer	1.07e-05	5.83e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.06e-05	5.77e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TYMS—lung cancer	1.05e-05	5.74e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCG2—lung cancer	1.05e-05	5.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ADCY1—lung cancer	1.05e-05	5.71e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—lung cancer	1.04e-05	5.68e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HPGDS—lung cancer	1.03e-05	5.6e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ENO2—lung cancer	1.03e-05	5.6e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.02e-05	5.57e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2A7—lung cancer	1.02e-05	5.56e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.01e-05	5.49e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SDC4—lung cancer	9.99e-06	5.44e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—lung cancer	9.98e-06	5.43e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1A1—lung cancer	9.88e-06	5.38e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2A6—lung cancer	9.86e-06	5.37e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GCLC—lung cancer	9.86e-06	5.37e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.83e-06	5.35e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ERCC2—lung cancer	9.8e-06	5.34e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ENO1—lung cancer	9.35e-06	5.09e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.32e-06	5.07e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.2e-06	5.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—RRM1—lung cancer	9.1e-06	4.96e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA3—lung cancer	9.1e-06	4.96e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—B4GALT5—lung cancer	8.56e-06	4.66e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOA1—lung cancer	8.48e-06	4.62e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2E1—lung cancer	8.39e-06	4.57e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA4—lung cancer	8.32e-06	4.53e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NQO1—lung cancer	8.29e-06	4.52e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.12e-06	4.42e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA2—lung cancer	8.11e-06	4.42e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.05e-06	4.38e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTA1—lung cancer	7.83e-06	4.26e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CG—lung cancer	7.74e-06	4.21e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCC3—lung cancer	7.74e-06	4.21e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKR1C1—lung cancer	7.5e-06	4.08e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—STK11—lung cancer	7.48e-06	4.07e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—POMC—lung cancer	7.37e-06	4.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UGT1A1—lung cancer	7.28e-06	3.96e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CREBBP—lung cancer	7.18e-06	3.91e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.02e-06	3.82e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GNG11—lung cancer	7.02e-06	3.82e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—lung cancer	6.92e-06	3.77e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CD—lung cancer	6.8e-06	3.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CAT—lung cancer	6.73e-06	3.66e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALB—lung cancer	6.72e-06	3.66e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.69e-06	3.64e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALDOA—lung cancer	6.68e-06	3.64e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCB1—lung cancer	6.55e-06	3.56e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA3—lung cancer	6.49e-06	3.53e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TYMS—lung cancer	6.43e-06	3.5e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—lung cancer	6.36e-06	3.46e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ADCY1—lung cancer	6.31e-06	3.43e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCG2—lung cancer	6.31e-06	3.43e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HPGDS—lung cancer	6.19e-06	3.37e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ENO2—lung cancer	6.19e-06	3.37e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.15e-06	3.35e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1A1—lung cancer	6.03e-06	3.28e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—lung cancer	6e-06	3.27e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ERCC2—lung cancer	5.98e-06	3.25e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CB—lung cancer	5.93e-06	3.23e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GCLC—lung cancer	5.93e-06	3.23e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2A6—lung cancer	5.93e-06	3.23e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—lung cancer	5.88e-06	3.2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ENO1—lung cancer	5.62e-06	3.06e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOA1—lung cancer	5.17e-06	2.81e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTEN—lung cancer	5.13e-06	2.79e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2E1—lung cancer	5.04e-06	2.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NQO1—lung cancer	4.99e-06	2.72e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.95e-06	2.7e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—EP300—lung cancer	4.89e-06	2.66e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CG—lung cancer	4.72e-06	2.57e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—STK11—lung cancer	4.5e-06	2.45e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—POMC—lung cancer	4.49e-06	2.45e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CREBBP—lung cancer	4.38e-06	2.38e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—lung cancer	4.16e-06	2.26e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CD—lung cancer	4.15e-06	2.26e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALB—lung cancer	4.1e-06	2.23e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CAT—lung cancer	4.05e-06	2.2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCB1—lung cancer	3.94e-06	2.14e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TYMS—lung cancer	3.87e-06	2.11e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—lung cancer	3.82e-06	2.08e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1A1—lung cancer	3.62e-06	1.97e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CB—lung cancer	3.62e-06	1.97e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3CA—lung cancer	3.62e-06	1.97e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ERCC2—lung cancer	3.59e-06	1.96e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—lung cancer	3.58e-06	1.95e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTEN—lung cancer	3.12e-06	1.7e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOA1—lung cancer	3.11e-06	1.69e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—EP300—lung cancer	2.98e-06	1.62e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKT1—lung cancer	2.95e-06	1.61e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CG—lung cancer	2.84e-06	1.55e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—POMC—lung cancer	2.7e-06	1.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CREBBP—lung cancer	2.63e-06	1.43e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CD—lung cancer	2.49e-06	1.36e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALB—lung cancer	2.46e-06	1.34e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3CA—lung cancer	2.2e-06	1.2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CB—lung cancer	2.17e-06	1.18e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—lung cancer	2.15e-06	1.17e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTEN—lung cancer	1.88e-06	1.02e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKT1—lung cancer	1.8e-06	9.81e-06	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—EP300—lung cancer	1.79e-06	9.76e-06	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3CA—lung cancer	1.33e-06	7.22e-06	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKT1—lung cancer	1.08e-06	5.9e-06	CbGpPWpGaD
